Cost effectiveness of a new strategy to identify HNPCC patients.
about
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disordersDevelopment and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy.Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data.Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impactElectronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial.Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value.Colorectal cancer screening with odour material by canine scent detection.DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics programCost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome.A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory.Integrative analysis of hereditary nonpolyposis colorectal cancer: the contribution of allele-specific expression and other assays to diagnostic algorithms.A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist's initiative.Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping reviewOptimizing the detection of hereditary non-polyposis colorectal cancer: an update.Genetic screening by DNA technology: a systematic review of health economic evidence.Most patients with colorectal tumors at young age do not visit a cancer genetics clinic.Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.A review of economic evaluations of genetic testing services and interventions (2004-2009).Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase.Genetic testing in the European Union: does economic evaluation matter?A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models.Improving recognition and referral of patients with an increased familial risk of colorectal cancer: results from a randomized controlled trial.Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective.Economic evaluation of genetic screening for Lynch syndrome in Germany.Which Lynch syndrome screening programs could be implemented in the "real world"? A systematic review of economic evaluations.Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.Limited diagnostic value of microsatellite instability associated pathology features in colorectal cancer.Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndromeThe cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
P2860
Q22330767-C2193ECA-B2C9-4C13-8972-38499D716CA8Q30484158-1343A775-50B9-4B0D-BFFA-DE0A9A93FA43Q31094568-5298184F-21A8-41FA-AC14-2E4D28CFFF8FQ33423923-636F7A45-AEFE-4FE4-B945-6969B09B5F72Q33892091-2517D05F-D3B8-4B79-A759-128CED240715Q34022038-F21D103D-4EA5-483E-9FF6-AD5484F33ECBQ34025558-ADA47B91-CE45-4238-9D9B-893042F13C5EQ34262449-9FDF757A-A21E-4214-A695-2626E632C0EEQ34380045-A2855E9B-EBEC-4259-B591-0349162222E8Q34543387-1653CAC6-FBFD-423F-9EE7-EBD7D58E478DQ35013990-CD5EB759-B679-4ACC-9F2F-1A1B6DEB6E53Q35053925-14A1391C-2887-489E-A118-35D80408D835Q35596050-A8F20E51-64B6-425A-A23F-4A4977EEC2DDQ36001501-D556D5FF-0AB7-4630-9285-9140FC2C0EE3Q36304418-1635FB21-5717-466D-B425-5994A65D80CDQ36510713-0F0DA4A7-1B5C-4FCA-BA02-7B3B0241838FQ36597619-D9407EA7-6215-4E69-BC47-1CEE8E556BC5Q36800267-3EDA7B60-7CC6-44A5-AF8B-A02A23BF85D2Q37221791-D9F943B5-C7CF-426F-A842-38FA6895A331Q37832922-83F35C12-50DE-45EE-BA2D-AF03AD32B58CQ37863222-F26DE9D6-54A9-4A31-9C53-C496185AAF1DQ37877618-E8D1F273-EA36-4AB9-9D4C-E2667AB61A43Q39039319-11096F16-BAE0-4924-9C68-4B3ABC6A3A00Q39071265-F8D40F5B-9802-4B82-B279-B2D22486642BQ44045870-4C8C21B6-4A29-49C8-AC43-D742C11E149DQ48237396-14871D03-9FF6-4C00-8BF3-417A6B60F7ADQ50195477-447B02AE-2B6B-4411-B781-12D38FB071D1Q50873130-C88F93C4-EC62-47BB-9AB9-21B75EA16851Q51747864-BAD81BA9-BC5C-44AF-9A7A-7B0ACB7ADCD8Q57259811-248AA80D-6198-4158-9533-75A8190D9F4FQ58635831-F7B15A82-A1F3-4F41-80F1-4A3A390195BC
P2860
Cost effectiveness of a new strategy to identify HNPCC patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cost effectiveness of a new strategy to identify HNPCC patients.
@ast
Cost effectiveness of a new strategy to identify HNPCC patients.
@en
type
label
Cost effectiveness of a new strategy to identify HNPCC patients.
@ast
Cost effectiveness of a new strategy to identify HNPCC patients.
@en
prefLabel
Cost effectiveness of a new strategy to identify HNPCC patients.
@ast
Cost effectiveness of a new strategy to identify HNPCC patients.
@en
P2093
P2860
P356
P1433
P1476
Cost effectiveness of a new strategy to identify HNPCC patients.
@en
P2093
E M M Adang
F M Nagengast
H F A Vasen
J H F M de Bruin
J H J M van Krieken
J H Kleibeuker
J L Severens
M J L Ligtenberg
R H Sijmons
P2860
P304
P356
10.1136/GUT.2004.039123
P407
P577
2005-01-01T00:00:00Z